Experimental Hematology
Volume 38, Issue 5 , Pages 373-383, May 2010

Heterogeneous expression and function of IL-21R and susceptibility to IL-21−mediated apoptosis in follicular lymphoma cells

  • Daniela de Totero

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • Drs. de Totero and Capaia contributed equally to this work.
  • ,
  • Matteo Capaia

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • Drs. de Totero and Capaia contributed equally to this work.
  • ,
  • Marina Fabbi

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  • ,
  • Michela Croce

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  • ,
  • Raffaella Meazza

      Affiliations

    • Istituto G. Gaslini, Genoa, Italy
  • ,
  • Giovanna Cutrona

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  • ,
  • Simona Zupo

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  • ,
  • Fabrizio Loiacono

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  • ,
  • Mauro Truini

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
  • ,
  • Manlio Ferrarini

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • DOBIG, University of Genoa, Genoa, Italy
  • ,
  • Silvano Ferrini

      Affiliations

    • Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy
    • Corresponding Author InformationOffprint requests to: Silvano Ferrini, M.D., CBA, Istituto Nazionale per la Ricerca sul Cancro, Largo Benzi 10, 16132 Genova, Italy

Received 26 May 2009; received in revised form 18 February 2010; accepted 22 February 2010. published online 02 March 2010.

Objective

Interleukin (IL)-21, a member of the IL-2 family, has antitumor activity and is now being tested in non-Hodgkin's lymphoma in combination with anti-CD20 antibodies. IL-21 may either induce apoptosis or promote growth in different lymphoid malignancies. We therefore investigated the IL-21/IL-21R system in follicular lymphoma (FL) cells.

Materials and Methods

IL-21R expression was studied by reverse transcription polymerase chain reaction, immunofluorescence, and Western blot analyses. Apoptosis was measured by Annexin-V−propidium iodide staining. Signaling via IL-21R was studied using antibodies specific for phosphorylated Janus-activating kinase and signal transducers and activators of transcription proteins by Western Blot.

Results

IL-21R was found on primary FL cells in 15 of 15 cases at diagnosis and IL-21 increased apoptosis in 10 of 10 FL samples. However, cells from areas of diffuse growth in FL and from two diffuse lymphomas evolved from previous FL, showed low IL-21R expression. The latter were also resistant to IL-21−mediated apoptosis. Among lymphoma cell lines bearing the t(14;18) translocation, only 1 of 7 showed increased apoptosis in response to IL-21 stimulation. This cell line was IL-21R−positive, whereas five of six nonresponsive cell lines showed very low IL-21R expression. Intriguingly, one of the IL-21-resistant cell lines (DOHH2) expressed high levels of IL-21R. Treatment with IL-21 or IL-4 upregulated suppressor of cytokine signaling 3 gene expression in the IL-21−responsive cell line, but not in DOHH2 cells, which showed defective Janus-activating kinase/signal transducers and activators of transcription signaling in response to IL-21, in relationship to the lack of Janus-activating kinase 3 gene expression.

Conclusion

These data indicate that low IL-21R expression or defective signal transduction downstream IL-21R may cause refractoriness to IL-21−mediated effects in some FL cells.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0301-472X(10)00053-6

doi:10.1016/j.exphem.2010.02.008

Experimental Hematology
Volume 38, Issue 5 , Pages 373-383, May 2010